Related Experiment Videos
Virus infection and dilated cardiomyopathy.
P J Richardson1, H J Why, L C Archard
1Cardiac Department, King's College Hospital, London, UK.
Postgraduate Medical Journal
|January 1, 1992
Summary
Virus infection, specifically enteroviruses, plays a role in dilated cardiomyopathy. Detecting enteroviral RNA in heart biopsies indicates a poor prognosis, but its clearance may signal improvement.
Area of Science:
- Cardiology
- Virology
- Pathogenesis
Background:
- Virus infection is increasingly implicated in dilated cardiomyopathy (DCM) development.
- Progression from myocarditis to DCM suggests a viral etiology.
- Histological diagnosis via endomyocardial biopsy is crucial for DCM diagnosis.
Purpose of the Study:
- To investigate the role of enteroviral RNA in dilated cardiomyopathy pathogenesis.
- To assess the prognostic value of enteroviral RNA detection in endomyocardial biopsies.
- To explore the potential impact of antiviral therapies on DCM progression.
Main Methods:
- Utilized enterovirus group-specific hybridization probes and polymerase chain reaction (PCR).
- Analyzed endomyocardial biopsy samples for the presence of enteroviral RNA.
- Correlated viral RNA detection with disease stage and patient prognosis.
Main Results:
- Enteroviral RNA sequences were detected in endomyocardial biopsies from DCM patients across all disease stages.
- Persistence of enteroviral RNA in the myocardium is associated with an adverse prognosis.
- Preliminary findings suggest viral clearance may correlate with clinical improvement.
Conclusions:
- Enteroviral RNA detection in endomyocardial biopsies is a significant prognostic marker for dilated cardiomyopathy.
- The persistence of enteroviruses in the heart may drive DCM pathogenesis.
- Future antiviral treatments hold promise for altering the natural history of enterovirus-induced DCM.